Previous studies suggested that pancreatic cancer had an immunosuppressive tumor microenvironment with high PD-L1 expression, which inhibited the cytotoxicity of activated T cells, and PD-L1 overexpression was associated with a poor prognosis (50, 51). This evidence concerns the gene CD274 and neoplasm.